Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim


About this study

The purpose of this study is to see if advanced endoscopic imaging may be helpful to accurately distinguish pathological tissue from normal tissue and guide therapy of endoscopically identified pathology.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Inflammatory bowel disease
  • Screening colonoscopy
  • Barrett's esophagus
  • Colon polyps
  • Celiac disease

Exclusion Criteria:

  • Platelet count <50,000
  • Unwilling to provide informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Michael Wallace, M.D.

Closed for enrollment

Rochester, Minn.

Mayo Clinic principal investigator

Nayantara Coelho-Prabhu, M.B.B.S.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer